Sentence examples for prevalence of dose from inspiring English sources

The prevalence of dose modifications owing to DRAEs (Supplementary Figure 1) was generally consistent with the prevalence data for DRAEs.

In the oldest patients, the prevalence of dose modifications owing to DRAEs tended to be higher than in younger patients; however, the relatively small number of patients in the oldest group after month 12 precludes meaningful conclusions.

The prevalence of dosing inadequacy in polymedicated patients over 65 years with renal impairment attending community pharmacies is not insignificant.

The mean of the prevalence of dosing inadequacy in this group was 17.5%[95%% CI 14.6 - 21.4] and the mean of DRPs per patient was 0.7 [95% CI 0.5-0.8] 0.5-0.8]1).

The mean of the prevalence of dosing inadequacy in this group was 15.5% [95% CI 14.5-16.6] and the mean of the DRPs per patient was 0.50 [95% CI 0.4-0.6] 0.4-0.6]2).

This study consists of two phases: Phase 1: To determine the prevalence of dosing inadequacy, an observational, multicentre, cross-sectional study was carried out.

In Phase 1 the objective was to determine the prevalence of dosing inadequacy in the elderly polymedicated population with renal impairment.

Table  4 shows the results when comparing the prevalence of dosing inadequacy and DRPs per patient between the control and intervention groups adjusted by age, diastolic blood pressure, creatinine, number of total drugs and comorbidity: T2DM.

Statistically significant differences were noted (p < 0.001) between the control and intervention groups in the prevalence of dosing inadequacy and in the DRP rate per patient following the pharmacists' interventions.

The difference in the prevalence of dosing inadequacy between the control and intervention group before the pharmacists' intervention was 0.73% [95% CI0 (−6.0) -7.5], and after the pharmacists' intervention it was 13.5% [95% CI 8.0-19.5].

The aims of this study were, firstly, to determine the prevalence of dosing inadequacy as a consequence of renal impairment in patients over 65 taking 3 or more drug products who were being attended in community pharmacies and, secondly, to evaluate the effectiveness of the community pharmacist's intervention in improving dosing inadequacy in these patients when compared with usual care.